The system is intended for properly selected trained users ≥22 years of age who have been stabilized on anticoagulation with vitamin K antagonists for ≥6 weeks.
Higher risk for second hemorrhagic stroke in blacks and Hispanics is not fully explained by hypertension severity.
More stroke survivors are not within the new recommended blood pressure targets compared with Joint National Committee report.
A greater burden of atrial fibrillation or flutter in patients with paroxysmal atrial fibrillation was associated with a higher risk for stroke when not taking anticoagulants.
The evidence for preventive benefits, no effect, or elevated risk for all-cause mortality was generally moderate- or low-quality.
Based on data from 4 states, in 2015, 35.5% of adult stroke survivors used outpatient rehab.
Similar number of out-of-range next INR values were seen in patients with and without extended testing interval.
The combination of clopidogrel and aspirin was associated with a reduced risk for major ischemic events, but also with increased risk for major hemorrhage within 90 days.
There were better functional outcomes in ischemic stroke with alteplase, but a small increased rate of intracranial hemorrhage.
The approval of Retacrit was based on a review of evidence that included human pharmacokinetic/pharmacodynamic data and clinical immunogenicity data which demonstrated a high degree of similarity between Retacrit and its reference product.
In this meta-analysis of prospective population-based studies, sickle cell trait (SCT) was not associated with any difference in risk for first ischemic stroke.
Patients with hypertension may lower their stroke risk with folic acid supplements.
Frequent sauna bathing is associated with reduced risk of future stroke in adults.
Physical therapy promotes the recovery of arm function and neuroplasticity in all patients with chronic stroke.
Andexxa, a recombinant modified human Factor Xa (FXa) protein, was approved under the FDA's Accelerated Approval pathway.
Anxiety may increase the risk for ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation.
Previous stroke within 3 months of surgical aortic valve replacement is risk factor for recurrent ischemic stroke and MACE.
Investigators assessed the impact of infarction patterns on the safety and effectiveness of dual antiplatelet therapy with clopidogrel and aspirin.
Tenecteplase administered within 4.5 hours after symptoms linked to higher reperfusion and better functional outcomes in ischemic stroke.
FGF-23 concentrations in the top quartile were independently linked to greater risk for CV death and heart failure hospitalization.
Complete reversal was seen within 4 hours in the majority of patients, as measured by ecarin clotting time (ECT 82%) or diluted thrombin time (dTT 99%). In addition, there was a low late of thrombotic events and no new safety events were reported.
Rapid deployment valve use linked to increased rates of pacemaker implantation and disabling stroke, but not mortality.
There was an increased risk for all-cause cardiovascular and cerebrovascular emergency department visits, especially in individuals older than 65.
Costs related to informal caregiving for patients with cardiovascular disease may increase to $128 billion by 2035.
Investigators conducted a meta-analysis of trials that reported functional outcomes and mortality rates among patients with intracerebral hemorrhage following intensive blood pressure lowering.
Worse scores in multiple domains tied to lower income, female sex, and disability.
Foreign-born US residents have lower prevalence of heart disease and stroke than US-born adults.
Social isolation linked to increased mortality among individuals with history of AMI or stroke
Stroke survivors reported that a systematic voiding program helped them regain autonomy and re-establish pattern of micturition.
Patent foramen ovale closure resulted in a lower recurrence of stroke in patients with cryptogenic stroke and high-risk PFO characteristics.
The Cardiology Advisor Articles
- Aldosterone Antagonists Improved Survival in STEMI Without Heart Failure
- CTEPH Increases Risk for Sleep Disordered Breathing
- Many AKI Reports in FAERS Linked to Drugs Not Recognized as Nephrotoxic
- NSAID Use Mediates CVD Risk in Osteoarthritis
- Sildenafil, Bosentan Combination vs Sildenafil Monotherapy in SSc-Associated PAH
- Stroke Risk Highest in Paroxysmal Afib With Greater Burden of Afib
- New Hypertension Guideline Discussed for Older Adults
- Celecoxib Associated With Lower MACE Risk Than Naproxen and Ibuprofen
- Composite Echo Score Predicts PH in Interstitial Lung Disease
- Brain Natriuretic Peptide Shows Promise as Biomarker in Group 1 PAH
- Fenofibrate Improves Cholesterol Levels in Type 2 Diabetes
- NSTEMI Risk for ICU Complications Predicted Using ACTION ICU Risk Score
- Permanent Pacemaker After TAVR Increases Mortality, Readmission Risks
- Cardiovascular Event Risk Down With Med Diet Plus Olive Oil, Nuts
- NSAID Use Mediates CVD Risk in Osteoarthritis